ISIN:CA1208311029

DGAP-News: Burcon to Participate in Upcoming Investor Conferences

Retrieved on: 
Saturday, March 5, 2022
Private Securities Litigation Reform Act, TSX, SEDAR, Forward-looking statement, Drink, U.S. Securities and Exchange Commission, The Ritz-Carlton Hotel Company, Roth Capital Partners, Company, Conference, Food, EDGAR, Risk, Taste, Ritz-Carlton Atlantic City, Legislation, NASDAQ, Food industry, Security (finance)

Vancouver, British Columbia, March 3, 2022 -- Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, today announced that it will participate at two upcoming investor conferences from March 13 to 17, 2022:

Key Points: 
  • Burcon is a global technology leader in the development of plant-based proteins for foods and beverages.
  • In 2019, Merit Functional Foods Corporation ("Merit Foods") was established between Burcon and three veteran food industry executives.
  • This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information.
  • Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.

DGAP-News: Burcon Announces Appointment of Peter H. Kappel as Interim CEO

Retrieved on: 
Saturday, March 5, 2022
Private Securities Litigation Reform Act, DVB Bank, TSX, Director, SEDAR, Forward-looking statement, Drink, U.S. Securities and Exchange Commission, Interim, Knowledge, Board, Company, Food, EDGAR, Risk, Taste, Legislation, NASDAQ, Food industry, Management, Nomura

Burcon Announces Appointment of Peter H. Kappel as Interim CEO

Key Points: 
  • Burcon Announces Appointment of Peter H. Kappel as Interim CEO
    The issuer is solely responsible for the content of this announcement.
  • Burcon Announces Appointment of Peter H. Kappel as Interim CEO
    Vancouver, British Columbia, March 1, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that Peter H. Kappel, Chairman of Burcon's board of directors, will assume the role of interim Chief Executive Officer ("CEO"), with immediate effect, until a successor is appointed by the Company's board of directors.
  • Mr. Kappel has served as a director on Burcon's board since 2016 and was appointed chairman of the board in September 2021.
  • Mr. Kappel has worked closely with management to achieve the transformational business relationships over the past few years.

DGAP-News: Burcon NutraScience Corp.: Burcon Reports Fiscal 2022 Third Quarter Results

Retrieved on: 
Thursday, February 17, 2022
NASDAQ, Webcast, Pulse, Meat, CEO, Bunge Limited, Legislation, Company, Calendar, SEDAR, Loss, EDGAR, Forward-looking statement, Certification, Solution, Negotiation, IP, Taste, Safety, Food industry, AA, Insurance, U.S. Securities and Exchange Commission, Partnership, Risk, Food, Patent, British Retail Consortium, Production, Private Securities Litigation Reform Act, Drink, Research, Program, TSX, CPG, Security (finance), Video game, Dietary supplement, Fine chemical, Vegetable oil, Legume, Management, Life insurance

Vancouver, British Columbia - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal third quarter ended December 31, 2021.

Key Points: 
  • Vancouver, British Columbia - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal third quarter ended December 31, 2021.
  • Burcon recorded $1.2 million as its share of loss in Merit Foods for the third quarter of fiscal 2022, as compared to $460,000 in the same year-ago quarter.
  • During fiscal 2022 third quarter, Burcon allocated $192,000 of IP expenses to deferred costs.
  • General and administrative expenses increased by $431,000 for the current fiscal quarter as compared to the same year-ago quarter.